1. Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study). Issue 2 (February 2020) Authors: Van Wyk, J.; Ajana, F.; Bisshop, F.; De Wit, S.; Osiyemi, Y.; Portilla, J.; Routy, J.; Wyen, C.; Ait-Khaled, M.; Nascimento, M.; Pappa, K.; Wang, R.; Wright, J.; Tenorio, A.; Wynne, B.; Aboud, M.; Gartland, M.; Smith, K.; El-Bahy, Y. Journal: Journal of infection and public health Issue: Volume 13:Issue 2(2020) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗